3-111884189-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001134438.2(PHLDB2):āc.112C>Gā(p.Leu38Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000805 in 1,614,180 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001134438.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PHLDB2 | NM_001134438.2 | c.112C>G | p.Leu38Val | missense_variant | 2/18 | ENST00000431670.7 | NP_001127910.1 | |
PHLDB2 | NM_001134439.2 | c.112C>G | p.Leu38Val | missense_variant | 2/18 | NP_001127911.1 | ||
PHLDB2 | NM_001134437.2 | c.193C>G | p.Leu65Val | missense_variant | 3/18 | NP_001127909.1 | ||
PHLDB2 | NM_145753.2 | c.112C>G | p.Leu38Val | missense_variant | 2/17 | NP_665696.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PHLDB2 | ENST00000431670.7 | c.112C>G | p.Leu38Val | missense_variant | 2/18 | 1 | NM_001134438.2 | ENSP00000405405.2 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152182Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000147 AC: 37AN: 251120Hom.: 0 AF XY: 0.000206 AC XY: 28AN XY: 135704
GnomAD4 exome AF: 0.0000814 AC: 119AN: 1461880Hom.: 1 Cov.: 32 AF XY: 0.000117 AC XY: 85AN XY: 727240
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152300Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74476
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 17, 2023 | The c.112C>G (p.L38V) alteration is located in exon 2 (coding exon 1) of the PHLDB2 gene. This alteration results from a C to G substitution at nucleotide position 112, causing the leucine (L) at amino acid position 38 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at